Rxi Pharmaceuticals (RXII) Stock Price, Quote, News and Overview
NASDAQ:RXII - Nasdaq -
RXII Quote, Performance and Key Statistics
0.33
0 (0%)
The current stock price of RXII is 0.33 null. In the past month the price decreased by -25%. In the past year, price decreased by -44.07%.
About RXII
Company Profile
RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. The Company is developing RXI-109, which is used for the reduction of dermal scarring in planned surgeries, as well as reduces the expression of connective tissue growth factor. RXi Pharmaceuticals Corporation is based in Worcester, Massachusetts.
Company Info
Rxi Pharmaceuticals
257 SIMARANO DRIVE SUITE 101
MARLBOROUGH MA 01752
CEO: Geert Cauwenbergh
Phone: 508-767-3861
Rxi Pharmaceuticals / RXII FAQ
What is the stock price of Rxi Pharmaceuticals today?
The current stock price of RXII is 0.33 null.
What is the ticker symbol for Rxi Pharmaceuticals stock?
The exchange symbol of Rxi Pharmaceuticals is RXII and it is listed on the Nasdaq exchange.
On which exchange is RXII stock listed?
RXII stock is listed on the Nasdaq exchange.
What is Rxi Pharmaceuticals worth?
Rxi Pharmaceuticals (RXII) has a market capitalization of 1.45M null. This makes RXII a Nano Cap stock.
Should I buy Rxi Pharmaceuticals (RXII) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of RXII, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of RXII, evaluating the profitability, health, valuation and growth aspects
- Rxi Pharmaceuticals (RXII) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Rxi Pharmaceuticals (RXII) Sales and EPS estimates to see what analysts future expectations are.
- Rxi Pharmaceuticals (RXII) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Rxi Pharmaceuticals (RXII) Insider and Institutional Ownership to learn about the owners and their transactions.
- Rxi Pharmaceuticals (RXII) Stock Chart to make your own analysis
- Rxi Pharmaceuticals (RXII) Latest news and press-releases to stay up to date.
Does Rxi Pharmaceuticals (RXII) stock pay dividends?
RXII does not pay a dividend.
What is the Price/Earnings (PE) ratio of Rxi Pharmaceuticals (RXII)?
Rxi Pharmaceuticals (RXII) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.3).
RXII Technical Analysis
RXII Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RXII. Both the profitability and financial health of RXII have multiple concerns.
RXII Financial Highlights
Over the last trailing twelve months RXII reported a non-GAAP Earnings per Share(EPS) of -3.3000000000000003. The EPS increased by 74.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -5532.61% | ||
| ROA | -200.45% | ||
| ROE | -436.29% | ||
| Debt/Equity | 0 |